These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 29545455)

  • 1. Glucocorticoids Are Associated with an Increased Risk for Vertebral Fracture in Patients with Rheumatoid Arthritis.
    Kim D; Cho SK; Park B; Jang EJ; Bae SC; Sung YK
    J Rheumatol; 2018 May; 45(5):612-620. PubMed ID: 29545455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and risk factors associated with vertebral osteoporotic fractures in patients with rheumatoid arthritis.
    Tong JJ; Xu SQ; Zong HX; Pan MJ; Teng YZ; Xu JH
    Clin Rheumatol; 2020 Feb; 39(2):357-364. PubMed ID: 31691041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of cumulative exposure to high-dose oral glucocorticoids on fracture risk in Denmark: a population-based case-control study.
    Amiche MA; Abtahi S; Driessen JHM; Vestergaard P; de Vries F; Cadarette SM; Burden AM
    Arch Osteoporos; 2018 Mar; 13(1):30. PubMed ID: 29552730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Average daily glucocorticoid dose, number of prescription days, and cumulative dose in the initial 90 days of glucocorticoid therapy are associated with subsequent hip and clinical vertebral fracture risk: a retrospective cohort study using a nationwide health insurance claims database in Japan.
    Iki M; Fujimori K; Nakatoh S; Tamaki J; Ishii S; Okimoto N; Imano H; Ogawa S
    Osteoporos Int; 2024 May; 35(5):805-818. PubMed ID: 38267664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association between 10-year fracture risk by FRAX and osteoporotic fractures with disease activity in patients with rheumatoid arthritis.
    Phuan-Udom R; Lektrakul N; Katchamart W
    Clin Rheumatol; 2018 Oct; 37(10):2603-2610. PubMed ID: 30039267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fracture risk in oral glucocorticoid users: a Bayesian meta-regression leveraging control arms of osteoporosis clinical trials.
    Amiche MA; Albaum JM; Tadrous M; Pechlivanoglou P; Lévesque LE; Adachi JD; Cadarette SM
    Osteoporos Int; 2016 May; 27(5):1709-18. PubMed ID: 26694595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High prevalence of asymptomatic vertebral fractures in post-menopausal women receiving chronic glucocorticoid therapy: a cross-sectional outpatient study.
    Angeli A; Guglielmi G; Dovio A; Capelli G; de Feo D; Giannini S; Giorgino R; Moro L; Giustina A
    Bone; 2006 Aug; 39(2):253-9. PubMed ID: 16574519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Systemic Glucocorticoid Use on Fracture Risk: A Population-Based Study.
    Koh JW; Kim J; Cho H; Ha YC; Kim TY; Lee YK; Kim HY; Jang S
    Endocrinol Metab (Seoul); 2020 Sep; 35(3):562-570. PubMed ID: 32981298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose relationship between oral glucocorticoids and tumor necrosis factor inhibitors and the risk of hospitalized infectious events among patients with rheumatoid arthritis.
    Schenfeld J; Iles J; Trivedi M; Accortt NA
    Rheumatol Int; 2017 Jul; 37(7):1075-1082. PubMed ID: 28255642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of fracture in women with glucocorticoid requiring diseases is independent from glucocorticoid use: An analysis on a nation-wide database.
    Adami G; Gatti D; Rossini M; Giollo A; Gatti M; Bertoldo F; Bertoldo E; Mudano AS; Saag KG; Viapiana O; Fassio A
    Bone; 2024 Feb; 179():116958. PubMed ID: 37949390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of fractures in women with rheumatoid arthritis and/or systemic lupus erythematosus on chronic glucocorticoid therapy.
    Rentero ML; Amigo E; Chozas N; Fernández Prada M; Silva-Fernández L; Abad Hernandez MA; Rodriguez Barrera JM; del Pino-Montes J;
    BMC Musculoskelet Disord; 2015 Oct; 16():300. PubMed ID: 26472426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of vertebral fractures in patients with rheumatoid arthritis: revisiting the role of glucocorticoids.
    Ghazi M; Kolta S; Briot K; Fechtenbaum J; Paternotte S; Roux C
    Osteoporos Int; 2012 Feb; 23(2):581-7. PubMed ID: 21350894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and risk factors associated with glucocorticoid-induced osteoporosis in Chinese patients with rheumatoid arthritis.
    Ma CC; Xu SQ; Gong X; Wu Y; Qi S; Liu W; Xu JH
    Arch Osteoporos; 2017 Dec; 12(1):33. PubMed ID: 28374332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucocorticoid exposure and fracture risk in patients with new-onset rheumatoid arthritis.
    Balasubramanian A; Wade SW; Adler RA; Lin CJF; Maricic M; O'Malley CD; Saag K; Curtis JR
    Osteoporos Int; 2016 Nov; 27(11):3239-3249. PubMed ID: 27273113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and Risk of Glucocorticoid-Associated Adverse Effects in Patients With Rheumatoid Arthritis.
    Wilson JC; Sarsour K; Gale S; Pethö-Schramm A; Jick SS; Meier CR
    Arthritis Care Res (Hoboken); 2019 Apr; 71(4):498-511. PubMed ID: 29856128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose oral glucocorticoid therapy and risk of osteoporotic fractures in patients with rheumatoid arthritis: a cohort study using the Clinical Practice Research Datalink.
    Abtahi S; Driessen JHM; Burden AM; Souverein PC; van den Bergh JP; van Staa TP; Boonen A; de Vries F
    Rheumatology (Oxford); 2022 Apr; 61(4):1448-1458. PubMed ID: 34255815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vertebral fractures are increased in rheumatoid arthritis despite recent therapeutic advances: a case-control study.
    Guañabens N; Olmos JM; Hernández JL; Cerdà D; Hidalgo Calleja C; Martinez López JA; Arboleya L; Aguilar Del Rey FJ; Martinez Pardo S; Ros Vilamajó I; Suris Armangué X; Grados D; Beltrán Audera C; Suero-Rosario E; Gómez Gracia I; Salmoral Chamizo A; Martín-Esteve I; Florez H; Naranjo A; Castañeda S; Ojeda Bruno S; García Carazo S; García Vadillo A; López Vives L; Martínez-Ferrer À; Borrell Paños H; Aguado Acín P; Castellanos-Moreira R; Tebé C; Gómez-Vaquero C;
    Osteoporos Int; 2021 Jul; 32(7):1333-1342. PubMed ID: 33459805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fracture risk with intermittent high-dose oral glucocorticoid therapy.
    De Vries F; Bracke M; Leufkens HG; Lammers JW; Cooper C; Van Staa TP
    Arthritis Rheum; 2007 Jan; 56(1):208-14. PubMed ID: 17195223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of symptomatic vertebral fractures in women of childbearing age newly treated with high-dose glucocorticoid.
    Sugiyama T; Suzuki S; Yoshida T; Suyama K; Tanaka T; Sueishi M; Tatsuno I
    Gend Med; 2010 Jun; 7(3):218-29. PubMed ID: 20638627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databases.
    Siris ES; Harris ST; Rosen CJ; Barr CE; Arvesen JN; Abbott TA; Silverman S
    Mayo Clin Proc; 2006 Aug; 81(8):1013-22. PubMed ID: 16901023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.